Clinical Trial Update: Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update notes that a Phase 2 study of autologous LN-145 (lifileucel) for metastatic non-small cell lung cancer is currently in the recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• LN-145 (autologous tumor-infiltrating lymphocytes)

Snippet

Sponsor: Iovance Biotherapeutics, Inc. | Conditions: Metastatic Non Small Cell Lung Cancer | Phase 2 | Status: RECRUITING